Authors
Loading...
Randomized trial demonstrates improved neoantigen identification in NSCLC using personalized vaccine strategy, suggesting better therapeutic outcomes.
Nicholas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: